COMPARISON OF 5-FLUOROURACIL (NSC-19893) AND 2'-DEOXY-5-FLUOROURIDINE (NSC-27640) IN TREATMENT OF PATIENTS WITH ADVANCED ADENOCARCINOMA OF COLON OR RECTUM.
D000230:Adenocarcinoma; D000970:Antineoplastic Agents; D003110:Colonic Neoplasms; D003857:Deoxyuridine; D004358:Drug Therapy; D005472:Fluorouracil; D006801:Humans; D009705:Nucleosides; D010166:Palliative Care; D012004:Rectal Neoplasms; D012007:Rectum; D014116:Toxicology; D014529:Uridine / Q000031:analogs & derivatives
D000970:Antineoplastic Agents; D009705:Nucleosides; C001943:5-fluorouridine; D005472:Fluorouracil; D003857:Deoxyuridine; D014529:Uridine
ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; COLONIC NEOPLASMS; DEOXYURIDINE; DRUG THERAPY; FLUOROURACIL; NUCLEOSIDES; PALLIATIVE TREATMENT; RECTAL NEOPLASMS; TOXICOLOGIC REPORT